MK-0524B

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK-0524B, covering 2016-01-26 to 2016-04-01. Get the full timeline:

Most recent: Clinical Trial Update: MK-0524B Lipid Study (MK-0524B-063) [Phase 3]